Literature DB >> 19188440

Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.

Shahram Misaghi1, Søren Ottosen, Anita Izrael-Tomasevic, David Arnott, Mohamed Lamkanfi, James Lee, Jinfeng Liu, Karen O'Rourke, Vishva M Dixit, Angus C Wilson.   

Abstract

Protein ubiquitination provides an efficient and reversible mechanism to regulate cell cycle progression and checkpoint control. Numerous regulatory proteins direct the addition of ubiquitin to lysine residues on target proteins, and these are countered by an army of deubiquitinating enzymes (DUBs). BRCA1-associated protein-1 (Bap1) is a ubiquitin carboxy-terminal hydrolase and is frequently mutated in lung and sporadic breast tumors. Bap1 can suppress growth of lung cancer cells in athymic nude mice and this requires its DUB activity. We show here that Bap1 interacts with host cell factor 1 (HCF-1), a transcriptional cofactor found in a number of important regulatory complexes. Bap1 binds to the HCF-1 beta-propeller using a variant of the HCF-binding motif found in herpes simplex virus VP16 and other HCF-interacting proteins. HCF-1 is K48 and K63 ubiquitinated, with a major site of linkage at lysines 1807 and 1808 in the HCF-1(C) subunit. Expression of a catalytically inactive version of Bap1 results in the selective accumulation of K48 ubiquitinated polypeptides. Depletion of Bap1 using small interfering RNA results in a modest accumulation of HCF-1(C), suggesting that Bap1 helps to control cell proliferation by regulating HCF-1 protein levels and by associating with genes involved in the G(1)-S transition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188440      PMCID: PMC2663315          DOI: 10.1128/MCB.01517-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  The HCF repeat is an unusual proteolytic cleavage signal.

Authors:  A C Wilson; M G Peterson; W Herr
Journal:  Genes Dev       Date:  1995-10-15       Impact factor: 11.361

2.  Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues.

Authors:  C N Larsen; J S Price; K D Wilkinson
Journal:  Biochemistry       Date:  1996-05-28       Impact factor: 3.162

3.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Authors:  D E Jensen; M Proctor; S T Marquis; H P Gardner; S I Ha; L A Chodosh; A M Ishov; N Tommerup; H Vissing; Y Sekido; J Minna; A Borodovsky; D C Schultz; K D Wilkinson; G G Maul; N Barlev; S L Berger; G C Prendergast; F J Rauscher
Journal:  Oncogene       Date:  1998-03-05       Impact factor: 9.867

4.  A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function.

Authors:  H Goto; S Motomura; A C Wilson; R N Freiman; Y Nakabeppu; K Fukushima; M Fujishima; W Herr; T Nishimoto
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

5.  VP16 targets an amino-terminal domain of HCF involved in cell cycle progression.

Authors:  A C Wilson; R N Freiman; H Goto; T Nishimoto; W Herr
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

6.  Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes.

Authors:  L C Dang; F D Melandri; R L Stein
Journal:  Biochemistry       Date:  1998-02-17       Impact factor: 3.162

7.  Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution.

Authors:  S C Johnston; C N Larsen; W J Cook; K D Wilkinson; C P Hill
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

8.  Viral mimicry: common mode of association with HCF by VP16 and the cellular protein LZIP.

Authors:  R N Freiman; W Herr
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

9.  Protein interactions in the herpes simplex virus type 1 VP16-induced complex: VP16 peptide inhibition and mutational analysis of host cell factor requirements.

Authors:  K A Simmen; A Newell; M Robinson; J S Mills; G Canning; R Handa; K Parkes; N Borkakoti; R Jupp
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

10.  Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3-3p21.3 in sporadic breast-cancer development.

Authors:  D L Buchhagen; L Qiu; P Etkind
Journal:  Int J Cancer       Date:  1994-05-15       Impact factor: 7.396

View more
  101 in total

Review 1.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

Review 2.  BAP1, a tumor suppressor gene driving malignant mesothelioma.

Authors:  Mitchell Cheung; Joseph R Testa
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 3.  The role of deubiquitinating enzymes in chromatin regulation.

Authors:  Boyko S Atanassov; Evangelia Koutelou; Sharon Y Dent
Journal:  FEBS Lett       Date:  2010-10-26       Impact factor: 4.124

4.  Important recent insights into the genetics and biology of malignant pleural mesothelioma.

Authors:  Robert McMillan; Marjorie Zauderer; Matthew Bott; Marc Ladanyi
Journal:  Ann Cardiothorac Surg       Date:  2012-11

5.  Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer.

Authors:  Moubin Lin; Liren Zhang; Michelle A T Hildebrandt; Maosheng Huang; Xifeng Wu; Yuanqing Ye
Journal:  Oncotarget       Date:  2017-08-24

6.  Deubiquitinating enzyme BAP1 is involved in the formation and maintenance of the diapause embryos of Artemia.

Authors:  Fan Yang; Sheng-Nan Jia; Yan-Qin Yu; Xiang Ye; Jun Liu; Ye-Qing Qian; Wei-Jun Yang
Journal:  Cell Stress Chaperones       Date:  2012-02-29       Impact factor: 3.667

7.  BAP1 is phosphorylated at serine 592 in S-phase following DNA damage.

Authors:  Ziad M Eletr; Luming Yin; Keith D Wilkinson
Journal:  FEBS Lett       Date:  2013-11-05       Impact factor: 4.124

8.  Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.

Authors:  Shumei Yan; Fan He; Rongzhen Luo; Huini Wu; Mayan Huang; Chunyu Huang; Yong Li; Zhiwei Zhou
Journal:  Tumour Biol       Date:  2015-11-26

9.  Stabilization of an unusual salt bridge in ubiquitin by the extra C-terminal domain of the proteasome-associated deubiquitinase UCH37 as a mechanism of its exo specificity.

Authors:  Marie E Morrow; Myung-Il Kim; Judith A Ronau; Michael J Sheedlo; Rhiannon R White; Joseph Chaney; Lake N Paul; Markus A Lill; Katerina Artavanis-Tsakonas; Chittaranjan Das
Journal:  Biochemistry       Date:  2013-05-09       Impact factor: 3.162

Review 10.  Connecting molecular pathways to hereditary cancer risk syndromes.

Authors:  Joseph R Testa; David Malkin; Joshua D Schiffman
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.